Analyst Ratings for Bellicum Pharmaceuticals (BLCM)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/15/2023 | Ladenburg Thalmann | Aydin Huseynov | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.86 (0.62) |
-27.91% | Details |
10/30/2020 | Wells Fargo | Jim Birchenough | Downgrade | Equal Weight (Overweight) |
4.50 (N/A) |
6.40 (0.62) |
-90.31% | Details |